Distributors / Reps

Find out how IMDA can help you achieve excellence in specialty sales and marketing.

  Save the Date

IMDA Conference 2018 date coming soon

Meet an IMDA Member - SOTA


State of the Art Medical Products
Cedar Grove, N.J.


Keith Lambie

State of the Art (SOTA) Medical Products has been in business for 30+ years.

We are a specialty medical sales and distribution company. SOTA's original sales territory ranged from the New York and Philadelphia metropolitan areas, and now includes all of New England, and goes as far south as Maryland.

Our management team has over 75 years of management, sales and clinical experience. In order to properly support our manufacturers and customers, and provide an integrated sales force within our geographical market.

 SOTA Medical Products has evolved into three separate sales teams servicing three distinct surgical markets:

  1. Advanced Surgical Technologies
  2. Cardiovascular/Interventional Procedures
  3. Surgical Division.

Supporting our sales team is a 7-person, in-house staff located in Cedar Grove, N.J with full logistical functionality

IMDA eNews       12/5/2017

 Infant screening for CCHD
Infant deaths from critical congenital heart disease decreased more than 33 percent in eight states that mandated screening for CCHD using pulse oximetry, reports the Centers for Disease Control and Prevention. In addition, deaths from other or unspecified cardiac causes decreased by 21 percent. CCHD screening nationwide could save at least 120 babies each year, according to a study published in the Journal of the American Medical Association. Forty-seven states and the District of Columbia now have mandatory screening policies in place, and one additional state – California -- requires screening be offered.

 Some bundling programs dismantled
The Centers for Medicare & Medicaid Services issued a final rule that cancels the cardiac and surgical hip and femur fracture treatment mandatory bundling payment programs, known as the episode payment models, reports AHA Today. It also cancels the cardiac rehabilitation incentive payment model. These programs had been scheduled to begin Jan. 1, 2018. The rule also finalizes revisions to certain aspects of the Comprehensive Care for Joint Replacement model, including giving certain hospitals selected for participation in the CJR model a one-time option to choose whether to continue their participation.

 Post-operative complications down in many procedures
A new study finds that most of 10 types of operations have improved rates of surgical site and bladder infections since 2008, reports the American College of Surgeons. However, the researchers did identify a need for prompt quality improvement for another operation, pancreatectomy, for which surgical site infections have significantly increased during the same timeframe. In addition to pancreatectomy, the procedures studied included colectomy, esophagectomy, hepatectomy, proctectomy, and thyroidectomy—removal of part or all of the, respectively, large intestine (colon) and bowel, esophagus, liver, rectum, and thyroid—as well as hysterectomy (removal of a woman’s womb). Also included were total hip replacement, total knee replacement, and repair of a ventral hernia, also called an abdominal wall hernia.

 Puerto Rico-based medical manufacturers still feeling hurricane's wrath
The medical industry in Puerto Rico continues to make progress following Hurricane Maria, but a lot of work remains, reports FDA Commissioner Scott Gottlieb, M.D. "We have been closely working with one supplier, Baxter, to help them restore production operations in their Puerto Rico facilities," said Gottlieb in an FDA blog. “We also approved IV solution products from Fresenius Kabi and Laboratorios Grifols to mitigate the shortage."The FDA remains concerned about the shortage of amino acids for injection. This product is of critical need for patients, including children and infants, who are not able to eat and need to receive their nutrition intravenously, according to Gottlieb. The hurricane disrupted Baxter's amino acids production facilities in Puerto Rico;Baxter is one of the largest manufacturers of this product serving the U.S. market.

 An inside look at the heart

Researchers in London published details of a cardiology needle capable of imaging the heart's soft tissues from within, reports MedGadget. The team from University College London and Queen Mary University of London used the ultrasound imaging system for heart surgery in pigs, successfully capturing high-resolution images up to 2.5cm away from the needle tip. The imaging needle relies on an embedded miniature optical fiber, which transmits brief pulses of light, which in turn generate ultrasonic pulses. These ultrasonic pulses propagate away from the needle, reflecting off soft tissues before being detected by a second optical fiber in the needle housing. For the first time live imaging can now be taken directly from inside the heart during keyhole surgery.

 The Internet of Things and medical devices

Ask your manufacturer partners: Would they like to be in deep contact with their medical device through its life cycle? In an MD+DI article entitled "What you need to know about the Internet of Things and medical devices," Sal Sanci, senior technology executive at StarFish Medical, asks manufacturers to envision the future: "Your team is able to observe when and how the device is used, and further, how it performs. Along with the benefits of this oversight, consider having a cost-effective path to modify your device as your team identifies issues. Imagine the potential serviceability of the device, the impact on consumables, the new usage models, and the opportunities for new business models. To plan for this future, we will look at the value that can be realized, how we address security, how we think about service, what the data is and how we realize its value, and what technologies are relevant."